Rare diseases
Investigational molecules
Locations
Discontinuing Acetylsalicylic Acid vs Continued Use in Patients ≥ 65 Years with Stable Chronic Coronary Syndrome
DenmarkEfficacy and safety of lunsekimig in adults with inadequately controlled eosinophilic COPD: a randomized, double‑blind, placebo‑controlled trial
DenmarkRinatabart Sesutecan plus bevacizumab vs standard care as maintenance for recurrent platinum‑sensitive ovarian cancer after second‑line chemotherapy
DenmarkStudy of hu14.18K322A with temozolomide and irinotecan in children and adolescents with high‑risk neuroblastoma
DenmarkRandomized Study of INCB161734 Plus Standard Chemotherapy Drug Combination in Untreated KRAS G12D Metastatic Pancreatic Ductal Adenocarcinoma Patients
DenmarkEfficacy and Safety of LTG-321 Compared with Placebo in Patients with Osteoarthritis of the Knee
DenmarkPhase II Study of Teclistamab Plus Pomalidomide in Patients with Relapsed/Refractory Multiple Myeloma After 1–3 Prior Therapies
DenmarkStudy of MK-1045 versus blinatumomab with tocilizumab in patients with relapsed or refractory B-cell acute lymphoblastic leukemia
DenmarkVenetoclax added to fludarabine, cytarabine and gemtuzumab ozogamicin (drug combination) in children with relapsed acute myeloid leukemia
DenmarkLong‑term immunity after a 6‑month‑old MMR vaccine (live attenuated) in infants: follow‑up of antibody levels 1‑3 years after routine vaccination
DenmarkA Phase 2/3 Study of intravitreal mk-8748 versus aflibercept in adults with neovascular age‑related macular degeneration
DenmarkEvaluation of NXT007 versus Emicizumab Prophylaxis in Patients with Hemophilia A
DenmarkTell us about your condition – we search every trial in Europe and connect you with the right site.
